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Abstract: Background: Cases of external hemorrhage are difficult to recognize on postmortem computed
tomography (PMCT). Purpose: To investigate the effects of blood loss on CT attenuation of the spleen,
liver, kidneys, and lungs on PMCT and to assess the relationship between blood loss and organ weight.
Methods: A total of 125 cases with blood loss were sex- and age-matched to 125 control cases without
blood loss. Individual organ attenuation was measured on transverse CT images. Organ weights of
the liver, spleen, kidneys, and lung were extracted from the autopsy protocols. Results: Organ weight
was significantly lower in cases with blood loss (lung 30%, spleen 28%, kidneys 14%, liver 18%) than
in controls. CT attenuation of the lungs was significantly lower (30%) in cases with blood loss than
in controls. CT attenuation of the spleen and kidneys did not significantly differ between cases and
controls. CT attenuation of the liver was significantly higher (25%) in cases with blood loss than in
controls. Conclusion: Blood loss decreases organ weight and CT attenuation of the lungs but appears to
have no significant effect on CT attenuation of the spleen and kidneys. The increased liver attenuation
in cases with blood loss compared to controls was an unexpected finding and remains challenging to
explain. One probable interpretation refers to different levels of hepatic glycogen; however, further work
is warranted to substantiate this hypothesis.
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Abstract
Background Cases of external hemorrhage are difficult to recognize on postmortem computed tomography (PMCT).
Purpose To investigate the effects of blood loss on CT attenuation of the spleen, liver, kidneys, and lungs on PMCT and to 
assess the relationship between blood loss and organ weight.
Methods A total of 125 cases with blood loss were sex- and age-matched to 125 control cases without blood loss. Indi-
vidual organ attenuation was measured on transverse CT images. Organ weights of the liver, spleen, kidneys, and lung were 
extracted from the autopsy protocols.
Results Organ weight was significantly lower in cases with blood loss (lung 30%, spleen 28%, kidneys 14%, liver 18%) 
than in controls. CT attenuation of the lungs was significantly lower (30%) in cases with blood loss than in controls. CT 
attenuation of the spleen and kidneys did not significantly differ between cases and controls. CT attenuation of the liver was 
significantly higher (25%) in cases with blood loss than in controls.
Conclusion Blood loss decreases organ weight and CT attenuation of the lungs but appears to have no significant effect on 
CT attenuation of the spleen and kidneys. The increased liver attenuation in cases with blood loss compared to controls was 
an unexpected finding and remains challenging to explain. One probable interpretation refers to different levels of hepatic 
glycogen; however, further work is warranted to substantiate this hypothesis.
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Introduction
Hemorrhage is a critical component of accidental and 
inflicted trauma but may also occur in cases of vascular 
ruptures due to malformation, inflammation, or neoplasia. 
The human body contains approximately 3.5–6.5 L of blood 
[1, 2], depending on sex and body mass. A loss of more 
than 40% of the total blood volume may lead to profound 
hypovolemic shock and death [3]. Significant hemorrhage 
and exsanguination are associated with typical findings at 
external inspection and autopsy. The loss of blood translates 
to a decreased outer lividity [4], and inner organs present 
with a distinctive pallor, particularly those with voluminous 
capillary systems, such as the liver, spleen, and kidneys [4]. 
It is not entirely clear if hemorrhagic hypovolemia affects 
organ weight as measured at autopsy. While comprehensible 
in theory, a decrease in organ weight due to blood loss has 
only been demonstrated by Boyd et al. [5] and Moar et al. 
[6], while Myers and Segal, as well as Hadley et al., did not 
consider hemorrhagic hypovolemia as a cause of observed 
differences in organ weight [7, 8].
Although hemorrhage and exsanguination may already 
be suspected after the external post-mortem examination, 
blood loss is surprisingly difficult to recognize on postmor-
tem computed tomography (PMCT). Particularly external 
hemorrhage is often elusive on PMCT. To date, only a few 
radiologic signs of substantial blood loss have been reported. 
Aghayev et al. observed a collapse of central vessels in cases 
of fatal hemorrhage [9]. This finding was later confirmed 
by Sogawa et al. [10], who also introduced and computed 
a vessel flattening index. Schober et al. investigated the 
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attenuation of lungs on PMCT with respect to the cause of 
death and observed decreased Hounsfield unit (HU) values 
both in cases of fatal hemorrhage and hypothermia [11].
The idea of measuring CT attenuation profiles of specific 
organs on PMCT in an attempt to link different HU values to 
different causes of death is very alluring and has also been 
tested for the liver and the spleen with moderate success 
[12, 13]. The main limitation of previous work on this topic 
was that most causes of death do not alter the composition 
of these organs. This is crucial because the attenuation of 
an absorber (such as an organ) on CT is determined by the 
composition of the absorber as well as by CT scan param-
eters (especially CT beam energy) [14].
Based on these fundamental principles of CT physics 
[14] and Schober’s work [11] on lung attenuation, this study 
hypothesized that hemorrhage—i.e. the removal of blood 
from organs—would decrease mean attenuation values of 
parenchymatous organs.
This study aimed to assess the effect of hemorrhage (i.e., 
the removal of blood) on CT attenuation of the spleen, liver, 
and kidneys on PMCT. To validate the methodology, the—
known—effect of blood loss on lung attenuation was also 
evaluated. The second aim of the study was to assess the 
relationship between blood loss and organ weight.
Methodology
Case and control case selection and matching
The institutional electronic case records were searched 
(period from 2015 to 2019) for cases with documented blood 
loss (either as the primary cause of death or in conjunction 
with lethal trauma) and for control cases with no blood loss. 
Each hemorrhage cases was sex- and age-matched (± 1 year) 
with a non-hemorrhage control case (referred to as cases 
and controls in the remaining manuscript). Individuals with 
successful on-scene resuscitation and delayed death after 
hospitalization were excluded. Attempted cardiopulmonary 
resuscitation (CPR) was noted. Cases were also excluded in 
the presence of any residues of contrast media from clinical 
CT examinations or postmortem angiography, visible lacera-
tions, neoplastic infiltration, and structural pathology (e.g., 
cirrhosis, fibrosis) of any of the target organs, streak artifacts 
from metallic implants, severe intrahepatic gas, and any gas 
in the spleen or kidneys signaling putrefaction or injury. A 
total of 125 cases for each group was included in the study. 
For each case, the time of death, time of PMCT, age, sex, 
height, weight, and estimated postmortem interval in (PMI) 
were extracted from the electronic case records. The body 
mass index (BMI) was calculated from height and weight.
Computed tomography
Non-contrast whole-body PMCT was performed using a 
128-slice scanner (Somatom Definition Flash, Siemens 
Medical Solutions, Forchheim, Germany). The reconstruc-
tion parameters were 120 kV, 1-mm slice thickness, 0.6-mm 
increment, and a 445 × 445 mm field of view. The scanner 
was regularly calibrated to a water standard. Reconstructions 
were calculated in a soft and a hard kernel. For each case, 
regions of interest (ROI) were manually placed on prede-
fined transverse slices of the right lung, liver, left kidney, and 
spleen (Fig. 1). The effect of intraparenchymal blood sedi-
mentation as a confounding factor for ROI measurements, as 
reported by Jackowski et al., was prevented by measuring the 
entire transverse organ area with a non-circular, polygonal 
ROI [15]. Although circular ROI are more frequently used 
for HU measurements than non-circular polygonal ROI in 
the literature, earlier work by Ruder et al. has shown that 
the shape of the ROI does not have a significant influence 
on HU value measurements [16]. The liver and spleen were 
measured at the level of the 11th thoracic vertebra with a 
maximum transverse ROI. The teres hepatis ligament and 
marginal hepatic gas accumulations were not included in 
the ROI. The left kidney was measured at the level of the 
first lumbar vertebra. The lung was measured on the last 
transverse slice cranial to the dome of the diaphragm. In the 
case of a right-sided pneumo- or hemothorax, the left lung 
was measured. For each ROI, the mean HU unit value was 
recorded. To test the inter-rater reliability of the methodol-
ogy, a second rater repeated the polygonal ROI measure-
ments for all livers with the same approach. For the resulting 
values, a two-way intraclass correlation coefficient (ICC) 
was 0.992 (F = 257, p < 0.001). The mean HU value of both 
liver measurements is the number reported in this study.
Autopsy
A board-certified forensic pathologist and a resident or 
two certified forensic pathologists conducted the autopsy 
according to the institutional standard. Height, body 
weight, and organ weights were noted. Both kidneys were 
weighed together. As per autopsy protocol, hepatic stea-
tosis was classified visually by a forensic pathologist as 0 
(no steatosis), 1 (mild steatosis), 2 (moderate steatosis), 
or 3 (severe steatosis).
Statistical analysis
The matching of cases and controls was assessed with stand-
ardized mean differences (SMD). Variables with an SMD 
of < 0.1 were considered balanced across cases and controls. 
The mean values of continuous variables were compared 
International Journal of Legal Medicine 
1 3
with t-tests, and the proportions of categorical variables 
were compared by chi-square tests. Multiple regression 
analysis was used to determine the associations of predictors 
and the CT attenuation of the liver and the lungs (depend-
ent variable or “response”), and to adjust for confounders 
[17]. Predictors in these models were the group membership 
(cases or controls), hepatic steatosis, sex, age at death, liver 
and lung weight, BMI, and PMI, and attempted CPR. To 
enable a comparison of the relative strength of the associa-
tion of the predictors and the attenuations of the lungs and 
the liver, the partial standardized coefficients (beta coeffi-
cients) were computed and plotted [18]. In the subgroup 
analysis of liver attenuation, the comparisons between the 
mean attenuations were achieved by an ANOVA followed 
by a Tukey-HSD test. A p value < 0.05 was considered sig-
nificant. All analyses and plots were computed with R [19].
Results
Study population
A complete overview of the generated data is shown in 
Table 1. With respect to the SMD, the matching variables 
(sex and age, SMD ~ 0, p ~ 1), and height (SMD = 0.06, 
p = 0.65) were balanced. Weight (SMD = 0.13, p = 0.323) 
and BMI (SMD = 0.1, p = 0.42) showed minor, non-
significant imbalances. The number of attempted CPR 
(SMD = 0.37, p = 0.007) was significantly higher in the 
control group than in the case group. Hepatic steatosis was 
slightly more prevalent in the case group (44.0%) than in the 
control group (35.2%; SMD = 0.18, p = 0.18). The causes of 
death for cases and controls are presented in Fig. 2.
Organ attenuation and weights
Univariate results for the organ attenuations and weights 
are displayed in Table 2. The lung attenuation of the cases 
was significantly lower (− 153.7, 30%, p < 0.001) than that 
of the controls, while the liver attenuation was significantly 
higher (12.2 HU, 25%, p < 0.001) than that in controls. The 
Fig. 1  Measured regions of interest. The liver and spleen were meas-
ured on the level of the eleventh thoracic vertebra with a maximum 
transverse ROI (a). Intrahepatic gas and the teres hepatis ligament 
were excluded from the ROI (b). The lung was measured on the first 
transverse slice that did not show any part of the liver (c). The left 
kidney was measured on the level of the first lumbar vertebra (d)
Table 1  Collected data with respect to the case and control groups
Control 
Group
Case Group p SMD
n 125 125
Sex = Female (%) 38 (30.4) 38 (30.4) 1.000  < 0.001
Age (mean (SD)) 54.40 (18.73) 54.16 (18.93) 0.919 0.013
Weight (mean (SD)) 76.24 (19.36) 74.03 (15.74) 0.323 0.125
Height (mean (SD)) 173.46 (9.19) 172.92 (9.56) 0.652 0.057
BMI (mean (SD)) 25.18 (5.47) 24.67 (4.55) 0.424 0.101
PMI (mean (SD)) 30.68 (31.71) 26.56 (27.70) 0.274 0.139
Liver fat (%) 0.619 0.169
0 80 (64.0) 70 (56.0)
1 19 (15.2) 23 (18.4)
2 22 (17.6) 26 (20.8)
3 4 (3.2) 6 (4.8)
REA = 1 (%) 58 (46.4) 36 (28.8) 0.006 0.370
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spleen and kidney attenuations did not show significant 
differences among cases and controls. The weights of all 
organs in the case group were significantly lower than the 
organ weights in the control group (p < 0.001) with a mean 
weight difference between the cases and controls of 30.4% 
for the lung, 17.7% for the liver, 27.7% for the spleen, and 
14.0% for the kidneys.
Multiple linear regression analysis
The summaries of the multiple linear regression models 
(analyses) for liver and lung attenuation are presented in 
Table 3 and Fig. 3. The group membership to the case 
group was a highly significant (p < 0.001) predictor for 
lung (− 64.3 HU) and liver (+ 10.62 HU) attenuation. 
Moderate (− 7.26 HU, p < 0.001) and severe hepatic stea-
tosis (− 12.32 HU, p < 0.001) were significant predictors 
for liver attenuation. Attempted CPR, age, and BMI were 
significant predictors in both models, while female sex was 
a significant predictor for lung attenuation, and PMI was 
a significant predictor for liver attenuation. Lung weight 
was a significant predictor in the lung model with a posi-
tive coefficient (0.15, p < 0.001), while liver weight was 
a significant predictor in the liver model with a negative 
coefficient (− 0.01, p < 0.01).
For the liver model, the standardized coefficients 
(relative strength of association) of liver fat content 
(− 0.24, − 0.53, − 0.91) and the group membership case-
group (0.78) followed by CPR (− 0.33) were the largest 
(Fig. 3). For the lung model, the standardized beta coeffi-
cients were largest for lung weight (0.42), attempted reani-
mation (0.42), and the case-group membership (− 0.4).
Liver attenuation of subgroups
In Fig. 4, the boxplots of the liver attenuation with respect 
to the causes of death in the case group are shown. The 
subgroups “internal hemorrhage” and “iatrogenic” present 
with lower average attenuation than all other causes of 
death. The mean attenuation value for internal hemorrhage 
is significantly lower (p < 0.03 for all comparisons) for all 
other causes of death but for iatrogenic.
Discussion
This postmortem case–control study investigated the effect 
of blood loss on CT attenuation values and the weight of the 
spleen, liver, kidneys and lungs on PMCT and found higher 
hepatic attenuation values and lower pulmonary attenuation 
values in cases with blood loss than in controls. No signifi-
cant change in splenic and renal attenuation between cases 
and controls was observed. The weight of all organs was 
significantly lower in cases than in controls.
Fig. 2  Treemap of the causes of death, n = 250; red/orange, cases; 
green/blue, controls; white text and numbers, classification of cause 
of death and numbers of cases
Table 2  Results of the 
univariate comparison of mean 
organ attenuation and weight
Control Group Case Group p
n 125 125
Liver attenuation (mean (SD)) 49.25 (10.84) 61.43 (13.35)  < 0.001
Lung attenuation (mean (SD))  − 501.82 (157.30)  − 655.58 (129.69)  < 0.001
Spleen attenuation (mean (SD)) 50.10 (6.33) 50.84 (6.20) 0.352
Kidney attenuation (mean (SD)) 41.57 (5.83) 40.90 (5.65) 0.362
Liver weight (mean (SD)) 1810.16 (482.60) 1489.18 (347.79)  < 0.001
Lung weight (mean (SD)) 1529.68 (435.06) 1064.88 (330.22)  < 0.001
Spleen weight (mean (SD)) 194.22 (100.40) 140.36 (58.73)  < 0.001
Kidney weight (mean (SD)) 321.05 (85.29) 275.98 (65.61)  < 0.001
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The difference in organ weight between the case group 
and control group strongly indicates that blood loss results 
in significant organ weight loss. This conclusion may appear 
trivial and intuitive; however, this issue has been discussed 
controversially in the existing literature [5–8]; our results 
support the findings of Boyd et al. [5] and Moar et al. [6].
As stated in the introduction, the attenuation of an 
organ is determined by the composition of the organ and 
by CT beam energy [14]. The effect of changing the com-
position of an organ was illustrated in the lungs: after the 
removal of blood (mean attenuation: 60 HU [20]), the 
relative contribution of intrapulmonary air (− 1000 HU, 
[14]) on lung attenuation increased sufficiently to decrease 
the mean attenuation value of the lungs. Our findings on 
lung attenuation are in agreement with those of Schober 
et al. [11]. This point is important because it underlines the 
validity of the methodology. However, decreased attenu-
ation of the lung on PMCT is not specific for blood loss 
but also observed in hypothermia and obstructive asphyxia 
[11, 21, 22].
In contrast to the results on pulmonary attenuation, this 
study found no significant difference in renal and splenic 
attenuation between cases and controls. This finding sug-
gests that the attenuation of blood does not significantly dif-
fer from the attenuation of renal and splenic parenchyma. 
The findings on splenic attenuation are indirectly corrobo-
rated by Chatzaraki et al., who reviewed splenic attenuation 
and size in correlation to various causes of death [13].
The high liver attenuation value in the case group after 
blood loss was an unexpected finding. Mean liver attenua-
tion was approximately 12 HU higher in cases with blood 
loss (61 HU) than controls without blood loss (49 HU). This 
difference in means is reinforced in the multiple regression 
analysis. The binary predictor “group membership: Case 
Group” is highly significant in both regression models. It is 
Table 3  Outputs from the multiple linear regression models for lung 
and liver attenuation
*** p < 0.001; ** p < 0.01; * p < 0.05
Liver attenuation Lung attenuation
Case Group (1) 10.62 *** -64.93 ***
Sex (Female) 2.12 16.75
Age -0.18 *** -1.65 ***
BMI -0.2 3.97 * 
PMI 0.07 **  -0.14
Lung Weight 0.00 0.15 ***
Liver Weight -0.01 **  0.01
Hepatic Steatosis - Mild -3.25 -17.67
Hepatic Steatosis - Moderate -7.26 *** -28.33
Hepatic Steatosis - Severe -12.32 *** 54.29
Reanimation (1) -4.42 **  69.19 ***
 N 250 250
R2 0.49 0.50
Fig. 3  Overview of the beta coefficients of the regression mod-
els as a measure of relative strength of association of the predic-
tors and the of the models for liver and lung attenuation. To obtain 
these beta-coefficients, the organ attenuations (responses) as well 
as continuous predictors were mean-centered and scaled by 1 
standard deviation (standardized)
Fig. 4  Boxplots of the liver attenuations in the case group stratified 
by the cause of death. Iatrogenic and internal hemorrhages present 
with lower average attenuation than all other causes of death
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negatively associated with lung attenuation and positively 
associated with liver attenuation.
This increased liver attenuation in cases of blood loss 
stands in opposition to both, the literature on the attenuation 
values of blood (mean 60 HU, range 40–90 HU) and liver 
parenchyma (weighted mean 50 HU, range mean 32–58 HU) 
on PMCT [12, 20] and the authors’ experience from liver 
attenuation measurements. Empirically, liver attenuation was 
often lower than the attenuation of blood in the portal (or 
hepatic) veins. This contradiction suggests the presence of 
a confounding factor.
There are several known causes for an increase in hepatic 
attenuation: According to Boll et al., the most frequent cause 
of elevated liver attenuation values on clinical non-contrast 
CT are high levels of hepatic glycogen [23]. Hepatic gly-
cogen levels can quickly change in function of diet and the 
intake of a single glycogen-rich meal is sufficient to raise 
hepatic attenuation by nearly 5 HU, while depleted glycogen 
storage lowers the hepatic attenuation by about 5 HU from 
baseline in healthy male volunteers [24]. By contrast, other 
causes for increased liver attenuation such as iron or copper 
storage disease are not only rare, but they are chronic condi-
tions, which evolve slowly over years [23, 25]. In view of 
this evidence, hepatic glycogen storage levels appear to be 
a likely candidate for the suspected confounding factor, if 
a difference between hepatic glycogen between cases and 
controls can be established.
Hepatic glycogen serves as stored fuel that can be 
released into the bloodstream as glucose if the body requires 
energy rapidly. Due to this, hepatic glycogen levels were his-
torically used to estimate the duration of the agonal phase: 
High levels of hepatic glycogen were interpreted as a sign 
of a short agonal phase, with death occurring before the 
depletion of hepatic energy storages. Low levels of hepatic 
glycogen were attributed to a long/er agonal phase dur-
ing which hepatic glycogen storages had been depleted. 
This method was introduced by the French physician and 
criminologist Lacassagne in the late nineteenth century and 
was later refined by the Austrian forensic pathologist Carl 
Meixner who confirmed the connection between high levels 
of hepatic glycogen and a short agonal phase [26, 27].
This connection between levels of glycogen in the liver 
and the duration of the agonal phase [26, 27] is relevant 
for the interpretation of the liver attenuation values in this 
study: It is possible that the high mean liver attenuation val-
ues in the case group were not caused by the loss of blood, 
but by the residual presence of glycogen. This interpretation 
would mean that the high liver attenuation values found in 
cases with significant hemorrhage were rather a marker of 
a short agonal phase than of the actual blood loss. Another 
possibility of the influence of agony time on liver attenu-
ation could be the association of prolonged agony with 
multiorgan failure, which could influence liver attenuation. 
A strong indicator for the influence of agony on liver attenu-
ation rather than blood loss is found in the subgroup analy-
sis (Fig. 3). Two causes of death present with much lower 
attenuations: internal and iatrogenic hemorrhages. These are 
the two causes of death within the case group in which a 
higher average agony time can be strongly assumed.
Estimating agony times is notoriously difficult and lit-
erature on this topic is old and scarce. According to a clas-
sification system of agonal phases from 1965 [28], deaths 
related to hemorrhage tend to have shorter agony times than 
non-hemorrhage-related deaths. Based on this crude clas-
sification, it is reasonable to assume that the mean agony 
time of the case group with blood loss was shorter than the 
mean agony time of the control group without blood loss 
(see Fig. 2 for an overview of causes of death for cases and 
controls). Connecting this assumption with the findings 
of Lacassagne and Meixner [26, 27] further implies that 
hepatic glycogen levels also ought to have been higher in the 
case group than in the control group. Finally, the association 
between hepatic glycogen levels and hepatic attenuation on 
CT [21, 22] suggests that high liver attenuation values on 
CT in cases with hemorrhage is not a sign of blood loss, but 
a sign of a relatively short agony time—which is thought to 
be linked with hemorrhage related deaths [26]. Prospective 
studies with quantitative analysis of liver glycogen levels as 
well as case-by-case estimations of agony times are required 
to investigate the potential correlation between hepatic atten-
uation on CT and agonal phases.
The beta-coefficients of other variables included in the 
models for reasons of controlling for possible confounding 
(Age, Sex, BMI, PMI, liver and lung weight) factors pre-
sented with small effect sizes (Fig. 3)—although partially 
statistically significant. An exception is attempted CPR, 
which shows a substantial effect on both liver and lung 
attenuation. This is likely the result of intravenous volume 
administration during CPR attempts which increases the vol-
ume status but decreases the hematocrit, similarly described 
in cases 75 and 77 in Schober et al. [11]. The significance of 
the organ weights very likely describes no causal relation-
ship between weight and attenuation. Instead, it is explained 
with the correlation of the organ weight to other covariates. 
As seen in the weight analysis, increased lung weights are 
strongly associated with the assignment to the control group 
and therefore capture some of the variance of the grouping 
variable (blood loss). The same is true for liver weight, but 
less pronounced, as the weight difference between the two 
groups is lower.
This study contains several limitations. It may be criti-
cized that the attenuation of the examined organs was 
measured with ROI instead of full segmentation. To keep 
the methodology practical for routine application, ROI 
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measurements were favored over organ segmentation. Organ 
segmentation is more time-consuming and requires dedi-
cated software. Also, there is evidence in the literature that 
ROI measurements feature a high reproducibility within an 
absorber and have no significant intra- or interrater vari-
ability [16]. A second limitation of the study is that hepatic 
fat content was only evaluated macroscopically. The authors 
acknowledge this limitation. Hepatic fat content is not rou-
tinely quantified microscopically at the authors’ institution 
and due to the retrospective approach of this study, the infor-
mation was no longer available. However, since this limita-
tion affected both cases and controls, and the proportions of 
macroscopic liver fat were not significantly different, a selec-
tion bias is unlikely to have affected the difference in means 
of liver attenuation. For future investigations regarding the 
association of agony times, glycogen, hepatic steatosis, and 
blood loss with liver attenuation, a prospective microscopic 
evaluation of hepatic steatosis is strongly preferred.
Conclusion
Blood loss decreases organ weight as well as CT attenuation 
of the lungs but appears to have no significant effect on CT 
attenuation of the spleen and kidneys. CT attenuation of the 
liver was higher in cases with blood loss than in controls 
without blood loss. The connection between hepatic attenu-
ation on CT and hepatic glycogen levels as well as historic 
work on agony times suggests that high liver attenuation 
values on PMCT are rather an indicator of a relatively short 
agony time than a sign of blood loss. However, further dedi-
cated work is required to investigate the potential impact of 
agony time on hepatic attenuation on PMCT.
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